OCU-410 Gene Therapy Preserves Visual Acuity and Slows GA Lesion Progression, with Jay Chhablani, MD Jay Chhablani, MD

Published Date: 21 Nov 2025

Recent phase 1/2 trial data indicate the safety and efficacy of the surgical, subretinal injection in monitoring cellular homeostasis.

Read Full News

Latest News

Mechanisms That Matter: Understanding Intravitreal Therapies for Retinal Vascular Diseases

Mechanisms That Matter: Understanding Intravitreal Therapies for Retinal Vascular Diseases

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

Eye Specialists Flag Concerns About Pricey Lenses in Cataract Surgery

Multifocal lenses are not for everyone, experts say

Anti-VEGF Agent Collects Big Win in Trial of Diabetic Retinopathy

More than 60% of tarcocimab-treated patients had reduced severity

New Agents for AMD Preserve Vision, Dramatically Reduce Treatment Burden

Bispecific antibody fares well against faricimab, two gene therapies extend treatment intervals

Consider This Before Cataract Surgery; Grant Rule: What's Next? CDC Nominee Grilled

MedPage Today reporters offer further insights into recently covered topics

Todays Updates

Abnormal Shadow on Chest Radiograph

Culture findings were key in making the diagnosis

Did Breast Cancer Radiation Cause This Weird Lung Problem?

Especially peculiar since the patient had no risk factors

Todays Updates

Abnormal Shadow on Chest Radiograph

Culture findings were key in making the diagnosis

Did Breast Cancer Radiation Cause This Weird Lung Problem?

Especially peculiar since the patient had no risk factors

Latest News

Mechanisms That Matter: Understanding Intravitreal Therapies for Retinal Vascular Diseases

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

Multifocal lenses are not for everyone, experts say

More than 60% of tarcocimab-treated patients had reduced severity

Bispecific antibody fares well against faricimab, two gene therapies extend treatment intervals

MedPage Today reporters offer further insights into recently covered topics

News All Time

Massage Matches Clinic Probing for Infant Tear Duct Blockage

Gently massaging the tear sacs of infants with blocked tear ducts may be as effective as clinic-based probing for clearing tearing and discharge, a noninferiority trial finds.

Can Dexamethasone Drops Prevent Retinal Disease in Preemies?

Dexamethasone eye drops administered in premature infants with early-stage retinal disease appear to reduce the odds of progression to treatment-requiring disease.

Urinary Drug Tadalafil Linked to Glaucoma Risk

Men taking tadalafil for lower urinary tract symptoms face a 22% higher risk of developing glaucoma than those who do not take the drug, a new study finds.

Study Links Uveitis to Higher Risk for Psychiatric Illness

Noninfectious uveitis is linked to higher rates of psychiatric comorbidities, with Black patients most affected, a new study finds.

Nonvalved Drainage Device Benefits Kids With Glaucoma

In children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years.

What Is Causing Progressive Vision Problems in a 32-Year-Old Woman?

A glaucoma diagnosis at a young age should prompt timely genetic testing

Woman Develops Chorioretinal Anastomosis at Site of Photocoagulation Scar

A serendipitous iatrogenic effect following laser surgery in a patient with NF1

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

GLP-1 Drug Linked to Cases of Rare Vision-Altering Condition

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism

Floaters Affect Vision of Kidney Transplant Patient

UL97- and UL54-resistant CMV retinitis treated with multivirus-specific T-cell therapy

What Caused Visual Disturbance in Kidney Transplant Patient?

Genetic testing identified PAX2 gene variant

Massage Gun Eye Injury: Retinal Tears, Detachment

'Hesitant historian' did not initially disclose that he used the product on his eyes

AI Smart Glasses Show Promise, Limitations as Aid for Patients With Low Vision

Good accuracy for recognizing common objects, mixed results by object size, colors, text, money

Loss of Payment Assistance for AMD Drugs Strains Patients and Ophthalmologists

— Pervasive "unsustainable" clinical practices amid cat-and-mouse game with funding availability

Recommended News For You

Prostate cancer detection with PET CT and PET MRI is comparable.

The Benefits of Exercise for Substance Use Disorders.

Inside the Major Findings From the NHS-Galleri Trial

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

Top 10 questions about breast cancer answered

FDA Authorizes Three Different Uses for Injectable Antibiotic.

Dementia-like protein buildup found in pancreas cells before cancer develops

Recommended Articles For You

Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models 

Artificial Intelligence for Hematopoietic Cell Lineage Dynamics Prediction 

Liquid Biopsy in Hematologic Malignancies: Current Evidence and Clinical Applications 

Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study: Rapamycin slows the progression of cancer by reducing aging and concentrating on precancerous cells.

2.

Can Alternating Venetoclax Regimens Improve AML Outcomes?

3.

Cancer detection recovered following pandemic disruptions

4.

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment

5.

Research identifies nearly 200 potential breast carcinogens in food packaging materials

1.

A Clinical Review of Novel Therapeutics for Rare Cancers in the Genomics Era

2.

The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy

3.

Unlocking the Mystery of Elliptocytes: Exploring the Unusual Shape of Red Blood Cells

4.

From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine 

5.

Uncovering the Causes of Thrombocytosis: A Journey to Improved Health

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Chemotherapy: What to Expect

2.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

3.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions

4.

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot